Pharming Group (PHAR) News Today $11.32 -0.68 (-5.67%) (As of 10:25 AM ET) Add Compare Share Share Today's Range$11.32▼$11.3550-Day Range$10.00▼$12.5052-Week Range$9.65▼$17.81Volume662 shsAverage Volume10,344 shsMarket Capitalization$757.77 millionP/E RatioN/ADividend YieldN/APrice Target$38.50 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePharming doses first paediatric patient in APDS therapy trialmsn.com - November 22 at 12:44 PMPharming Group’s Promising Clinical Trials and Regulatory Advancements Drive Analyst’s Buy Ratingmarkets.businessinsider.com - November 22 at 7:44 AMPharming Group: Positive Outlook Based on Leniolisib’s Global Regulatory Traction and Successful Joenja Launchmarkets.businessinsider.com - November 11 at 7:21 AMPharming Group ADR PHARmorningstar.com - November 6 at 6:38 PMPharming Group PHARMmorningstar.com - November 4 at 3:41 PMPharming Group N.V.: Pharming Group to participate in November investor conferencesfinanznachrichten.de - November 1 at 8:21 AMPharming Group to participate in November investor conferencesfinance.yahoo.com - November 1 at 8:21 AMPharming Group N.V. 2023 Q3 - Results - Earnings Call Presentationseekingalpha.com - October 26 at 9:34 AMmarketbeat.com - September 29 at 3:58 PMPharming Group N.V.: Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholdersfinanznachrichten.de - September 25 at 3:12 PMPharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholdersmarkets.businessinsider.com - September 25 at 3:12 PMRBC Capital Reaffirms Their Buy Rating on Pharming Group (PHGUF)markets.businessinsider.com - September 6 at 11:54 PMPharming Group to participate in September investor conferencesfinance.yahoo.com - August 24 at 2:49 AMPharming Group to convene Extraordinary General Meeting of Shareholdersfinance.yahoo.com - August 14 at 3:00 AMPharming Group enrols first patient in APDS therapy trialmsn.com - August 10 at 9:42 AMPharming Group N.V.: Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japanfinanznachrichten.de - August 9 at 1:36 AMPharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japanprnewswire.com - August 9 at 1:00 AMPharming Group N.V. 2023 Q2 - Results - Earnings Call Presentationseekingalpha.com - August 5 at 4:32 AMPharming Group (PHAR) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - July 27 at 2:59 AMPharming Group Nominates Richard Peters To Become Chairmannasdaq.com - July 18 at 7:46 AMPHAR - Pharming Group N.V.finance.yahoo.com - July 7 at 2:04 PM'Don't talk to strangers.' Top scams on seniors for 2023 and how to defend yourselfmsn.com - June 18 at 3:41 PMPharming sells rare pediatric disease PRV to Novartis for $21.1Mmsn.com - June 1 at 12:57 PMPharming announces sale of priority review voucherfinance.yahoo.com - June 1 at 2:36 AMPharming Group to attend the following Investor Conferences in Junefinance.yahoo.com - May 25 at 9:47 AMPharming Group N.V.: Pharming Group reports on results of the 2023 Annual General Meeting of Shareholdersfinanznachrichten.de - May 17 at 2:53 PMPharming Group reports on results of the 2023 Annual General Meeting of Shareholdersfinance.yahoo.com - May 17 at 2:53 PMLactoferrin and Lactoperoxidase Market with Future Opportunities 2023-2030marketwatch.com - May 16 at 1:50 PMAssociated Capital Group GAAP EPS of $0.81, revenue of $2.47Mmsn.com - May 11 at 8:46 PMPharming Group N.V.: Pharming Group reports financial results for the first quarter of 2023finanznachrichten.de - May 11 at 5:45 AMLactoferrin and Lactoperoxidase Market [2023-2030] | Global Size and Growth Developmentsmarketwatch.com - May 8 at 4:44 PMHereditary Angioedema Market Size by 2030marketwatch.com - April 28 at 8:23 PMHereditary Angioedema Treatment Market Outlook by 2031marketwatch.com - April 27 at 6:24 PMPharming Group: Small Company, Unclear Management Style, Low Volumeseekingalpha.com - April 17 at 12:50 PMPharming Group (NASDAQ:PHAR) Sees Large Growth in Short Interestmarketbeat.com - April 14 at 12:53 PMPharming Group N.V.: Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023finanznachrichten.de - April 13 at 7:41 AMPharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023finance.yahoo.com - April 13 at 7:41 AMPharming Group: Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.finanznachrichten.de - April 11 at 9:18 AMPharming Group convenes the Annual General Meeting of Shareholders 2023finance.yahoo.com - April 5 at 8:06 AMPHAR Pharming Group N.V.seekingalpha.com - March 31 at 4:58 PMPharming Group shares are trading higher after Oppenheimer maintained an Outperform rating and raised its price target from $36 to $40.benzinga.com - March 29 at 10:14 AMOppenheimer Maintains Outperform Rating for Pharming: Here's What You Need To Knowmarkets.businessinsider.com - March 28 at 2:09 PMUS FDA approves PharmingaEUR(TM)s Joenja to treat APDSmarketwatch.com - March 28 at 8:48 AMPharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Upfinance.yahoo.com - March 27 at 1:32 PMBioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Mondaybenzinga.com - March 27 at 12:17 PMPharming announces US FDA approval of Joenja(R) (leniolisib) as the first and only treatment indicated for APDSmarketwatch.com - March 26 at 5:37 PMU.S. judge rules Internet Archive's digital book lending violates copyrightsreuters.com - March 25 at 1:40 AMPharming Stock Reaps Significant Gains After Landmark FDA Approvalmarkets.businessinsider.com - March 25 at 1:40 AMPharming Announces FDA Approval of Joenja, ADRs Rise 46%marketwatch.com - March 24 at 8:36 PMADRs End Mostly Lower, Pharming Group Trades Activelymarketwatch.com - March 24 at 8:36 PM Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address PHAR Media Mentions By Week PHAR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼0.000.53▲Average Medical News Sentiment PHAR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼01▲PHAR Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ETNB News Today VERV News Today COGT News Today TNGX News Today DYN News Today OLMA News Today NAMS News Today ZNTL News Today BMEA News Today SLRN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:PHAR) was last updated on 12/11/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.